New drug aims to heal gut lining in tough Crohn's cases

NCT ID NCT06681324

Ongoing Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an experimental drug called AZD7798 in 24 adults with active Crohn's disease who have an ileostomy. The goal is to see if the drug is safe and can help repair the gut lining compared to a placebo. Participants will be monitored for side effects and changes in their gut health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Crohn disease Inflammation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CROHN'S DISEASE

Contacts and locations

Locations

Research Site

Leuven, 3000, Belgium
Research Site

Padova, 35121, Italy
Research Site

Roma, 00168, Italy
Research Site

Rozzano, 20089, Italy
Research Site

Amsterdam, 1081 HV, Netherlands
Research Site

Nijmegen, 6525 GA, Netherlands
Research Site

Warsaw, 04-501, Poland
Research Site

Linköping, 581 85, Sweden
Research Site

Stockholm, 17176, Sweden
Research Site

Kyiv, 02002, Ukraine
Research Site

Kyiv, 04210, Ukraine
Research Site

Vinnytsia, 21029, Ukraine
Research Site

Birmingham, B15 2GW, United Kingdom
Research Site

Cambridge, CB2 0XY, United Kingdom
Research Site

London, E1 1BB, United Kingdom
Research Site

London, NW10 7NS, United Kingdom
Research Site

London, WC1E 6AG, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.